Munich Re/Ergo Corporate Venture Fund - aVenture Asset Manager Research
Location
Düsseldorf, North Rhine-Westphalia, DE
Founded
1880
Munich Re/Ergo Corporate Venture Fund focuses on Series B investments, primarily targeting companies that align with their strategic interests in digital transformation within the insurance sector. The firm leverages its global presence, particularly in Europe and Asia, to identify and support innovative ventures that can benefit from their extensive industry expertise and network.
Notable portfolio companies include Fair, which has raised $385 million, and Ridecell, with $28 million in funding. Key decision-makers at the firm are deeply integrated within the Munich Re and ERGO ecosystem, ensuring that portfolio companies receive not only financial backing but also strategic guidance and access to a broad array of industry resources. This combination of capital and strategic support positions their investments for sustainable growth and market impact.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies2
Current Portfolio Count2
Top Investment Stages
Series B2 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
